Literature DB >> 12788999

Breast and ovarian cancer.

Richard Wooster1, Barbara L Weber.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12788999     DOI： 10.1056/NEJMra012284

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  133 in total

1.  The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.

Authors:  Foon Wu-Baer; Thomas Ludwig; Richard Baer
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

2.  High proportion of novel mutations of BRCA1 and BRCA2 in breast/ovarian cancer patients from Castilla-León (central Spain).

Authors:  Mar Infante; Mercedes Durán; Eva Esteban-Cardeñosa; Cristina Miner; Eladio Velasco
Journal:  J Hum Genet       Date:  2006-06-07       Impact factor: 3.172

3.  BRCA1 and BRCA2 in breast cancer predisposition and recombination control.

Authors:  Ralph Scully; Anyong Xie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-07       Impact factor: 2.673

Review 4.  Functional assays for BRCA1 and BRCA2.

Authors:  Marcelo A Carvalho; Fergus J Couch; Alvaro N A Monteiro
Journal:  Int J Biochem Cell Biol       Date:  2006-08-18       Impact factor: 5.085

5.  Management of breast cancer in women with BRCA gene mutation.

Authors:  Malcolm R Kell; John P Burke
Journal:  BMJ       Date:  2007-03-03

6.  Targeting health disparities: a model linking upstream determinants to downstream interventions.

Authors:  Sarah Gehlert; Dana Sohmer; Tina Sacks; Charles Mininger; Martha McClintock; Olufunmilayo Olopade
Journal:  Health Aff (Millwood)       Date:  2008 Mar-Apr       Impact factor: 6.301

7.  Targeting tumor suppressor networks for cancer therapeutics.

Authors:  Xuning Emily Guo; Bryan Ngo; Aram Sandaldjian Modrek; Wen-Hwa Lee
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

8.  Rapid and cost effective screening of breast and ovarian cancer genes using novel sequence capture method in clinical samples.

Authors:  Kristóf Arvai; Péter Horváth; Bernadett Balla; Anna M Tőkés; Bálint Tobiás; István Takács; Zsolt Nagy; Péter Lakatos; János P Kósa
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

9.  Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes.

Authors:  Soma Ghosh; Surojit Sur; Sashidhar R Yerram; Carlo Rago; Anil K Bhunia; M Zulfiquer Hossain; Bogdan C Paun; Yunzhao R Ren; Christine A Iacobuzio-Donahue; Nilofer A Azad; Scott E Kern
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

10.  BRCA2: Shining light on the regulation of DNA-binding selectivity by RAD51.

Authors:  Aura Carreira; Stephen C Kowalczykowski
Journal:  Cell Cycle       Date:  2009-11-06       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.